Skip to main content

AusPAR: Sofosbuvir / Velpatasvir / Voxilaprevir

Australian Public Assessment Report
Device/Product Name
Vosevi
Active ingredients
Sofosbuvir / Velpatasvir / Voxilaprevir
AusPAR Date
Published
Submission Number
PM-2016-04442-1-2
Submission Type
New chemical entity in fixed dose combination
Decision
Approved

Help us improve the Therapeutic Goods Administration site